David Altshuler, EVP, Chief Scientific Officer: Vertex Pharmaceuticals VRTX Sell · Filed 25/02/28

Trade details

Type: Insider sale
Amount: $610,560
Shares · price: 1,272 sh · $480.00 a share
Held after: 32,974 sh
Stock: Vertex Pharmaceuticals VRTX
Person: David AltshulerEVP, Chief Scientific Officer
Trade date: 25/02/27
Filed: 25/02/28
Days to filing: 1 days

Sold 3.7% of holdings

Share of holding sold: 3.7%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/28~25/03/29

David Altshuler's recent trades

David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/19
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/15
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/17
Traded 25/03/13
David AltshulerEVP, Global Research and CSO
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/13
Traded 25/03/13
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/12
Traded 25/03/10

David Altshuler, Chief Officer — sold $610.6K of Vertex Pharmaceuticals VRTX · 3.7% of holdings · 10b5-1 plan | Whalegun